地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18327026838
邮箱:sales@amyjet.com

艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

Coriell Institute for Medical Research成立于1953年的美国;目前,Coriell拥有并管理着世界上最大的生物样本库,包括细胞系、DNA及其他生物样本。
艾美捷科技有限公司代理Coriell Institute公司产品,依靠多年生物样本进口经验,为中国广大研究者提供包括LCL from B-Lymphocyte(B淋巴母细胞系)、Fibroblast(成纤维细胞)、细胞(系)DNA及其他生物样品产品。
LCL from B-Lymphocyte

More》》
<Fibroblast

More》》
<DNA from Cell or Cell Lines

More》》
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Coriell Institute"> Coriell InstituteNanostructured & Amorphous Materials, Inc.致力于纳米材料科技的应用。主要的业务包括:生产、研发、加工纳米级和非结晶材料。
Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. We are a leading nanomaterials company involved in all aspects of the business: manufacturing, research and development, processing, supplying and marketing of nanostructured materials and their dispersions.
Nanostructured & Amorphous Materials的主要产品包括:
Application-Oriented Carbon-Nanotubes Products
Carbon Nanotubes & Nanofibers
Carbon Nanotube Dispersions
Elements, Oxides, Carbides & Nitrides Nanoparticles
Fullerene
Graphenes, Graphene Oxides & Graphene Nanoplatelets
Graphene Film
Nanopowder Dispersions
Nanowires & Nanorods
Amorphous Ribbons
Nanocrystalline Ribbons
Amorphous & Nanocrystalline Cores
Amorphous and Nanocrystalline Magnetic Bars
Amorphous & Nanocrystalline Powders
Amorphous Brazing Foils
Superhard Materials
Surface-Modified Oxide Nanoparticles
| 品名 | 货号 | 规格 |
| CNTs Additives for Lithium-ion Battery | 1376YJ | 1kg; |
| Carbon Nanotubes Fibers | 1356YJ | meter; |
| Carbon Nanotubes Papers | 1348YJ | piece; |
| Carbon Nanotubes Films | 1350YJ | piece; |
| Carbon Nanotubes Films | 1351YJ | 咨询 |
| Water-based carbon nanotubes coatings | 1332YJ | kg; |
| Water-based carbon nanotubes coatings | 1333YJ | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJA | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJB | kg; |
| Conductive/heating carbon-nanotubes coatings | 1378YJA | kg; |
| 20wt% CNTs/80wt% ABS Masterbatch | 1335YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HDPE Masterbatch | 1337YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HIPS Masterbatch | 1338YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% LLDPE Masterbatch | 1339YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PA6 Masterbatch | 1340YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PP Masterbatch | 1341YJ | 1kg; 5kg; 10kg; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Dispersion | 8040YJ | 500g; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Dispersion | 8042YJ | 500g; |
| 2 wt% MWCNTs (> 98%, D 5-15 nm)/Water Dispersion | 8028YJ | 500ml; |
| 2 wt% MWCNTs-COOH (> 98%, D 5-15 nm)/Water Dispersion | 8027YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/Water Dispersion | 8030YJ | 500 ml; |
| 10 wt% MWCNTs-COOH (>98%, D 30-80 nm)/Water Dispersion | 8029YJ | 500 ml; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Paste | 8038YJ | kg; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Paste | 8039YJ | 500g; kg; |
| 2 wt% MWCNTs (> 95%, D 5-15 nm)/Water Paste | 8032YJ | kg; |
| 2 wt% MWCNTs-COOH (> 95%, D 5-15 nm)/Water Paste | 8033YJ | kg; |
| 10 wt% MWCNTs (> 95%, D 30-80 nm)/Water Slurry | 8034YJ | kg; |
| 10 wt% MWCNTs-COOH (> 95%, D 30-80 nm)/Water Paste | 8035YJ | kg; |
| 12-14 wt% MWCNTs (> 95%, D 30-80 nm)/Water Paste | 8036YJ | kg; |
| 12-14 wt% MWCNTs-COOH (>95%, D 30-80 nm)/Water Paste | 8037YJ | kg; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/BA Dispersion | 8116YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMAC Dispersion | 8118YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMF Dispersion | 8115YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/IPA Dispersion | 8117YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/NMP Dispersion | 8114YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/BA Dispersion | 8124YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/BA Dispersion | 8123YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMAC Dispersion | 8126YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMAC Dispersion | 8125YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMF Dispersion | 8122YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMF Dispersion | 8121YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/IPA Dispersion | 8130YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/IPA Dispersion | 8129YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/NMP Dispersion | 8120YJ | 500 ml; |
| 5 wt% MWCNTs (> 98%, D 30-80 nm)/NMP Dispersion | 8119YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/PMA Dispersion | 8128YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/PMA Dispersion | 8127YJ | 500 ml; |
| Fullerence powder (C60, 95+%) | 8072YJ | 1g; 5g; |
| Fullerence powder (C60, 98+%) | 8073YJ | 1g; 5g; |
| Fullerence powder (C60, 99+%) | 8074YJ | 1g; 5g; |
| Fullerene powder (C60, 99.5+%) | 8075YJ | 1g; 5g; |
| Fullerene powder (C60, 99.9+%) | 8076YJ | 1g; 5g; |
| Fullerence powder (C70, 95+%) | 8077YJ | 1g; 5g; |
| Fullerence powder (C70, 98+%) | 8078YJ | 1g; 5g; |
| Fullerence powder (C70, 99+%) | 8079YJ | 1g; 5g; |
| Fullerenol Powder (hydroxylated fullerence C60) | 8080YJ | 1g; 10g; |
| Three-Dimensional Graphene (> 60 wt%, D 6-8 um, 3-4 layers) | 8109YJ | 1g; 5g; |
| 1.0-1.5 wt% Graphenes (> 98 wt%, Dia. 4-6 um, < 10 layers)/NMP paste | 8064YJ | 1g (graphene); 5g (graphene); |
| Highly Elastic Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8095YJ | 1 cylinder; 5 cylinders; |
| Ultra-light Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8093YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 1.2 cm, Height 1.2 cm) | 8090YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8091YJ | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8096YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8096YJB | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8097YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8097YJB | 1 cylinder; 5 cylinders; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam (nickel foam etched, thickness 1-1.2 mm) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| 1-3 wt% Graphene Oxide (> 98 wt%, D 1-5 um, 1-2 layers)/Water Gel, pH = 3-4 | 8047YJB34 | 1g (graphene oxide); 5g (graphene oxide); |
| Graphene Oxide Paper (Dia. 9 cm, thickness 10 um) | 8089YJ | 1 piece; 5 pieces; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-13 um, < 30 layers) | 8055YJ2 | 50g; 250g; 1kg; |
| 5 wt% Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers)/NMP Paste | 8059YJ | kg (paste); |
| Industrial-Grade Graphene-Nanoplatelets/Carbon-Nanotubes Composites (> 90 wt%) | 8071YJ | 50g; 100g; |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/Water Paste | 8060YJ | kg (paste); |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/NMP Paste | 8061YJ | kg (paste); |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Silver Nanopowder (Ag, 99.9+%, 20 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7031HW | 500ml; 1L; |
| Silver Nanopowder (Ag, 99.9+%, 50 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7033HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 100 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7035HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 200 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7038HW | 500ml; |
| Gold Nanopowder (Au, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7041HW | 500ml; |
| Platinum Nanopowder (Pt, 99.9+%, 20-30nm) 0.1wt% Dispersion in Water | 0488HW | 500ml; |
| Palladium Nanopowder (Pd, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7051HW | 500ml; |
| Palladium Nanopowder (Pd, 99.9+%, 10 nm) 0.1wt% Dispersion in Water | 0466HW | kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) Dispersed in 850ml of Ethanol | 0388HW | 咨询 |
| Aluminum Oxide (alpha, 20 wt%, 30-60nm) in Water | 7017WJWA | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 30 nm) in Water | 7017WJWG | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 10 nm) in water | 7016WJWG | 1kg; |
| CuO, 1 wt%, in water, APS 30 nm | 9019WJ | kg; |
| Silicon Oxide (15 wt%, 30 nm) in water | 7019WJ | 30kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7015WJ | 1kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7016WJ | 1kg; 10kg; |
| Titanium Oxide (Rutile, 40 wt%, 30-50 nm) in water | 7013WJWR | 1kg; |
| Titanium oxide TiO2 (40wt%, Rutile, 30-50 nm ) in Isopropanol | 5006WJ | kg; |
| Titanium Oxide (TiO2, Rutile, >99.5%, 5-30 nm,15 wt%) in water | 7012WJWR | 1kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in IPA | 7014WJWA | 1kg; |
| Titanium Oxide (Anatase, ATO doped, 20 wt%, 15-25 nm) Slurry | 7030WJ | 5kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in water | 7012WJWA | 1kg; |
| Titanium Oxide (Anatase, 15 wt%, 5-30 nm) in water | 7011WJWA | 1kg; |
| Titanium Oxide (TiO2, Anatase, >99.5%, 15 nm, 15 wt%) in water, negatively charged | 7011WJWANC | 咨询 |
| Titanium Oxide Nanopowder (anatase, 5 wt%, 10-20 nm) in ethanol | 7019HT | 1L; 5L; |
| Zinc Oxide (20 wt%, 40 nm) in water | 7006WJ | 1L |
| Indium Tin Oxide (ITO, 30 wt%, 20-30 nm) in Water | 7026HZW | 100g; |
| Silver nanowires (Dia. 70 - 80 nm, Length > 10 um) | 0475HW6 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (Dia. 30 - 50 nm, Length > 10 um) | 0475HW5 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver Nanowires (Dia. 20 - 30 nm, Length > 10 um) | 0475HW4 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW2E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW2I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW2W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW3E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW3I | 1 g (Ag nanowires); 2 g (Ag nanowires); 3 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in water) | 0475NW3W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW5E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW5I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in water) | 0475NW5W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW6E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW6I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW6W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Single-walled Carbon nanotubes - 60%SWNTs (90%CNTs) | 1283YJ | 1g; 5g; |
| SWNT-OH (90% CNTs, 60% SWNTs) | 1285YJF | 1g; 5g; |
| SWNT-COOH (90% CNTs, 60% SWNTs) | 1287YJF | 1g; 5g; |
| Short SWNTs (90% CNTs, 60% SWNTs) | 1281YJS | 1g; 5g; |
| SWNT-OH (> 60%, OD 1-2 nm, Length 1-3 um) | 1285YJFS | 1g; |
| SWNT-COOH (> 60%, OD 1-2 nm, Length 1-3 um) | 1287YJFS | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | g; |
| Single-walled carbon nanotubes - 90%SWNTs (95%CNTs) | 1284YJ | g; 5g; |
| SWNT-OH (95% CNTs, 90% SWNTs) | 1286YJF | 1g; |
| SWNT-COOH (95% CNTs, 90% SWNTs) | 1288YJF | 1g; |
| SWCNTs (> 90%, OD 1-2 nm, Length 1-3 um) | 1246YJS | 1g; 5g; |
| Single-Walled Carbon Nanotubes (90+%), -OH Functionalized | 1586YJF | 1g; |
| Single-Walled Carbon Nanotubes (90+%), -COOH Functionalized | 1588YJF | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | 1g; |
| High-Purity SWNTs, -OH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1368YJF | 1g; |
| High-Purity SWNTs, -COOH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1369YJF | 1g; |
| High-Purity Short SWNTs (> 95%, OD 1-2 nm, Length 1-3 um) | 1372YJ | 1g; |
| High-Purity Short SWNTs, -OH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1373YJF | 1g; |
| High-Purity Short SWNTs, -COOH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1374YJF | 1g; |
| High-Purity SWNTs (> 95%), -NH2 functionalized | 1370YJF | 1g; 5g; |
| High-Purity Short SWNTs (> 95%), -NH2 functionalized | 1371YJFS | 1g; 5g; |
| High-Purity SWNTs (> 95 %, surface area > 1,075 m2/g) | 1300YJ | 1g; |
| DWNTs (> 60%, OD 2-4 nm, Length ~50 um) | 1280YJD | 1g; 5g; 25g; |
| DWNTs-COOH (> 60%, OD 2-4 nm, Length ~50 um) | 1281YJD | g; |
| Multi-Walled Carbon Nanotube -MWNT (98%, OD 4-6 nm) | 1389YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98%, OD 5-15 nm) | 1203YJ | 10g; 25g; |
| Multi-walled carbon nanotube -MWNT (99%, OD 5-15 nm) | 8101YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (95+%, OD 8-15 nm) | 1204YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 10-20 nm) | 1205YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 20-30 nm) | 1229YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98+%, OD 30-50 nm) | 1231YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 30-80 nm) | 1233YJ | 10g; 25g; |
| Short MWNT (98+%, OD 4-6 nm, Length 0.5-2 um) | 1392YJS | 5g; |
| Short MWNT (98+%, OD 5-15 nm, Length 0.5-2 um) | 1225YJS | 5g; |
| Short MWNT (99+%, OD 5-15 nm, Length 0.5-2 um) | 8104YJS | 5g; |
| Short MWNT (95+%, OD 8-15 nm, Length 0.5-2 um) | 1235YJS | 5g; |
| Short MWNT (>98%, OD 10-20 nm, Length 0.5-2 um) | 1236YJS | 10g; |
| Short MWNT (98+%, OD 20-30 nm, Length 0.5-2 um) | 1237YJS | 5g; |
| Short MWNT (98+%, OD 30-50 nm, Length 0.5-2 um) | 1238YJS | 5g; |
| Short MWNT (98+%, OD 30-80 nm, Length 0.5-2 um) | 1227YJS | 5g; |
| Graphitized MWNT (99.9%, OD 8-15 nm) | 1219YJ | 10g; 25g; |
| Graphitized MWNT (99.9%, OD 10-20 nm) | 1220YJ | 10g; |
| Graphitized MWNT (99.9%, OD 20-30 nm) | 1221YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-50 nm) | 1222YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-80 nm) | 1223YJ | 5g; |
| Industrial-grade MWNT (95+%, OD 4-6 nm) | 1395YJ | 1kg; |
| Industrial-Grade MWNT (95+%, OD 5-15 nm) | 1201YJG | 1kg; |
| Industrial-grade MWNT (95%, OD 8-15 nm) | 1201YJA | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-20 nm) | 1201YJB | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-30 nm) | 1201YJC | 1kg; |
| Industrial-grade MWNT (95+%, OD 20-40 nm) | 1201YJD | 1kg; |
| Industrial-Grade MWNT (95+%, OD 30-80 nm) | 1201YJE | 1kg; |
| MWNT-OH (98+%, OD 4-6 nm) | 1390YJF | 10g; |
| MWNT-OH (98+%, OD 5-15 nm) | 1261YJF | 5g; |
| MWNT-OH (99+%, OD 5-15 nm) | 8103YJF | 5g; |
| MWNT-OH (95+%, OD 8-15 nm) | 1262YJF | 5g; |
| MWNT-OH (98+%, OD 10-20 nm) | 1263YJF | 5g; |
| MWNT-OH (98+%, OD 20-30 nm) | 1264YJF | 5g; 25g; 100g; |
| MWNT-OH (98+%, OD 30-50 nm) | 1265YJF | 5g; |
| MWNT-OH (98+%, OD 30-80 nm) | 1266YJF | 5g; |
| Short MWNT-OH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1393YJF | 5 g; 100 g; |
| Short MWNT-OH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1247YJF | 5g; |
| Short MWNT-OH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8106YJF | 5g; |
| Short MWNT-OH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1248YJF | 5g; |
| Short MWNT-OH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1249YJF | 5g; |
| Short MWNT-OH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1251YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1252YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1253YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 8-15 nm) | 1224YJF | 1g; |
| Graphitized MWNT-OH (99.9%, OD 10-20 nm) | 1228YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 20-30 nm) | 1235YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-50 nm) | 1239YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-80 nm) | 1240YJF | 1g; 5g; |
| Industrial-grade MWNT-OH (95+%, OD 5-15 nm) | 1201YJI | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 8-15 nm) | 1201YJL | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 10-30 nm) | 1207YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 20-40 nm) | 1208YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 30-80 nm) | 1209YJF | 1kg; |
| MWNT-COOH (98+%, OD 4-6 nm) | 1391YJF | 10g; |
| MWNT-COOH (98+%, OD 5-15 nm) | 1267YJF | 5g; |
| MWNT-COOH (99+%, OD 5-15 nm) | 8102YJF | 10g; |
| MWNT-COOH (95+%, OD 8-15 nm) | 1268YJF | 5g; |
| MWNT-COOH (98+%, OD 10-20 nm) | 1269YJF | 5g; |
| MWNT-COOH (98+%, OD 20-30 nm) | 1270YJF | 5g; |
| MWNT-COOH (98+%, OD 30-50 nm) | 1271YJF | 5g; |
| MWNT-COOH (98+%, OD 30-80 nm) | 1272YJF | 5g; |
| Short MWNT-COOH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1394YJF | 5g; |
| Short MWNT-COOH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1254YJF | 5g; |
| Short MWNT-COOH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8105YJF | 5g; |
| Short MWNT-COOH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1255YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1256YJF | 5g; |
| Short MWNT-COOH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1257YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1259YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1273YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 8-15 nm) | 1241YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 10-20 nm) | 1242YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 20-30 nm) | 1243YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 30-50 nm) | 1244YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 30-80 nm) | 1245YJF | 1g; 5g; |
| Industrial-grade MWNT-COOH (95+%, OD 5-15 nm) | 1201YJH | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 8-15 nm) | 1201YJK | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 10-30 nm) | 1210YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 20-40 nm) | 1216YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 30-80 nm) | 1218YJF | 1kg; |
| Aligned MWNT (98+%, OD 8-15 nm, Length: 30-50 um) | 1215YJA | 25g; |
| Carbon nanofibers (70+%, D = 200-600 nm, L = 5-50 um) | 1177YJ | 10g; |
| Carbon Nanofibers (95+%, D = 50-200 nm, L = 1-15 um) | 8107YJ | 10g; |
| Graphitized carbon nanofibers (95+%, OD = 50-200 nm, L = 1-15 um) | 1178YJ | 10g; |
| Graphene (> 98 wt%, D > 50 um, < 3 layers) | 2191YJ | 1g; 5g; |
| Graphene Oxide (> 99 wt%, D 0.5-3 um, < 3 Layers) | 2192YJ | 1g; 5g; |
| Graphene Nanoplatelets (> 99.5 wt%, D 5-10 um, < 20 layers) | 8056YJ | 1g; 5g; 25g; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers) | 8055YJ | 50g; 250g; 1kg; |
| *60% Ni/38% MWNT (95+%, OD 8-15 nm) | 1293YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 10-20 nm) | 1294YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 20-30 nm) | 1295YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-50 nm) | 1296YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-80 nm) | 1297YJ | 10g; |
| MWNT-NH2 (95+%, OD 8-15 nm, 0.45 wt% amino) | 1562YJF | 5g; |
| Nitrogen-doped MWNTs (98%, OD 30-80 nm) | 8054YJ | 5g; |
| Large inner diameter thin-walled multi-walled carbon nanotubes | 1563YJF | 5g; |
| Coiled CNTs (60+%, OD 100-200 nm, Length 1-10 um) | 1298YJ | 5g; |
| Silver Nanopowder (Ag, 99.99%, 400 nm ) | 0487HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 200 nm ) | 0479HW | 咨询 |
| Silver Nanopowder (Ag, 99.99%, 100 nm ) | 0489HW | 咨询 |
| Silver Nanopowder (Ag, 99%, 90-210 nm) | 0471CD | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm ) | 0475HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm, w/~0.3% PVP ) | 0476HW | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 40 nm ) | 0473HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 40 nm, w/~0.3% PVP ) | 0474HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 30-50 nm, w/0.2 wt% PVP) | 0477YD | 咨询 |
| Silver Nanopowder (Ag, 35 nm, 99.5%, metal basis) | 0476JY | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 20 nm ) | 0477HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 20 nm, w/~0.3% PVP ) | 0478HW | 咨询 |
| Aluminum Powder (99.9%, 500 um) | 0156HW | 咨询 |
| Aluminum Powder (99.9%, 50 um) | 0154HW | 咨询 |
| Aluminum Powder (99.9%, 5 um) | 0152HW | 咨询 |
| Aluminum Nanoparticles (99.9%, 500 nm) | 0150HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 70-80 nm) | 0137HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 70-80 nm, w/PVP) | 0140HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 40-50 nm) | 0138HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 40-50 nm, w/PVP) | 0139HW | 咨询 |
| Aluminum Nanopowder (Al, 99+%, metal basis, 18 nm) | 0136JY | 咨询 |
| Gold (Au) Nanopowder (99.9%, 50-100 nm) | 0795CD | 咨询 |
| Gold (Au) Nanopowder (25nm, 99.9%) | 8801HW | 咨询 |
| Gold (Au) Nanopowder (10-20 nm, 99.95%) | 8796HW | 咨询 |
| Gold (Au) Nanopowder (10nm, 99.9%) | 8799HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.9%, 80-100 nm) | 0832HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.5%, 40-60 nm) | 0831HW | 咨询 |
| Nano Activated Carbon (C, 88+%, 100 nm) | 1211NH | 咨询 |
| Diamond Nanopowder (synthesized, 55-70%, 4-15nm) | 1311JGY | 咨询 |
| Diamond Nanopowder (synthesized, 98+%, 3-10 nm) | 1321JGY | 咨询 |
| Diamond Nanopowder (synthesized, 97%, 3-6 nm) | 1350SL | 咨询 |
| Graphite Nanopowder (400 nm, 99.9%) | 1250HT | 咨询 |
| *Cobalt Nanopowder, Carbon Coated (Co, 99%, 40 nm) | 0286HW | 咨询 |
| *Cobalt Nanopowder (Passivated, 99.8%, 28 nm) | 0276JY | 咨询 |
| *Chromium Nanopowder (Cr, 99.5%, 50 nm) | 0240XX | 咨询 |
| *Copper Nanopowder (Cu, 99%, 500 nm) | 0293HW | 100g; |
| *Copper Nanopowder (Cu, 99.9%, 200 nm) | 0290HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 100 nm) | 0298HW | 25g; |
| *Copper Nanopowder (Partially Passivated, 99+%, 80 nm) | 0294HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 70 nm) | 0291HW | 25g; |
| *Copper Nanopowder (Cu, 99.5%, 50-80 nm) | 0292HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 40 nm) | 0295HW | 25g; |
| *Copper Nanopowder (Cu, carbon coated, 99.8%, 25 nm) | 0297JY | 5g; |
| *Iron Nanopowder (Fe, 99.9%, 500nm) | 0272YM | 100g; 1kg; |
| *Iron Nanopowder (Fe, 99.9%, 100 nm) | 0264HW | 25g; |
| *Iron Nanopowder (Fe, 99.9%, 70 nm) | 0263HW | 25g; 100g; |
| *Iron Nanopowder (Fe, 99.9%, 40 nm) | 0262HW | 25g; 100g; |
| *Iron nanopowder, carbon coated (Fe/C, 99.6%, 25 nm) | 0267JY | 25g; |
| Germanium Nanopowder (Ge, 99.9+%, 600 nm) | 0327HW | 25g; |
| Germanium Nanopowder (Ge, 99.9%, 500 nm) | 0331HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) | 0326HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 300 nm) | 0325HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 200 nm) | 0323HW | 100g; kg; |
| Germanium Nanopowder (Ge, 99.9+%, 150 nm) | 0322HW | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, < 100 nm) | 0322HH | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, 20-50 nm) | 0321HW | 5g; |
| Iridium Nanopowder (Ir, 99.95%, 20-30 nm), wet powder in Deionized Water | 0771HW | 咨询 |
| *Molybdenum Nanopowder (Mo, 99.5%, 70 nm) | 0423HW | 咨询 |
| Niobium Nanopowder (Nb, 99.9%, 40-60 nm) | 0411HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 800 nm) | 0302HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 400 nm) | 0301HW | 100g; 1kg; |
| *Nickel Nanopowder (Ni, 99+%, 300 nm) | 0289HW | 1kg; |
| *Nickel Nanopowder (Ni, 99.5%, 100 nm) | 0285HW | 25g; |
| *Nickel Nanopowder (Ni, 99.9%, 80 nm) | 0284HW | 300g; |
| *Nickel Nanopowder (Ni, 99.5%, 70 nm) | 0288HW | 25g; |
| *Nickel Nanopowder (Ni, 99.5%, 40 nm) | 0283HW | 25g; |
| *Nickel Nanopowder, carbon coated (Ni/C, 99.9%, 20 nm) | 0287JY | 5g; |
| Palladium Nanopowder (Pd, 99.95%, 20-30 nm) | 0462HW | 咨询 |
| Platinum Nanopowder (Pt, 99.95%, 20-30 nm) | 0782HW | 咨询 |
| Platinum Nanopowder, PVP coated (Pt, 99.95%, 20-30 nm) | 0787HW | 1g; |
| Platinum Nanopowder (Pt, 99.9%, 20-30 nm) | 0786HW | 1g; 5g; |
| Rhodium Nanopowder (Rh, 99.95%, 20-30 nm) | 0451HW | 咨询 |
| Ruthenium Nanopowder (Ru, 99.95%, 20-30 nm) | 0441HW | 1g; |
| *Silicon Nanopowder (Si, 99%, 400 nm) | 0144HW | 100g; |
| *Silicon Nanopowder (Si, 99.9%, 100 nm) | 0149HW | 100g; |
| *Silicon Nanopowder (Si, > 97%, 50 nm) | 0145KE | 咨询 |
| *Silicon Nanopowder (Si, 99%, 30-50 nm) | 0147HW | 50g; |
| *Silicon Nanopowder (Si, 98+%, 30-50 nm) | 0141JS | 50g; 100g; 500g; 1kg; |
| Tin Nanopowder (Sn, 70 nm, w/PVP ) | 5522HW | 500g; |
| Tin Nanopowder (Sn, 99.9%, 60-80 nm) | 0501HW | 咨询 |
| *Tantalum Nanopowder (Ta, 99.9%, 40 nm) | 0225HW | 25g; |
| *Tantalum Nanopowder (Ta, 99.9%, 70 nm) | 0224HW | 25g; |
| *Titanium Nanopowder (Ti, 99%, 60-80 nm) | 0227HW | 25g / $361; |
| *Tungsten Powder (W, 99.5+%, 1-2 um) | 0747HW | 100g; |
| *Tungsten Nanopowder (W, 99.5%, 500 nm) | 0749HW | 1kg; |
| *Tungsten Nanopowder (W, 99.5%, <100 nm) | 0745HW | 100g; |
| *Zinc Nanopowder (Zn, 99%, 500 nm) | 0318HW | 1kg; |
| *Zinc Nanopowder (Zn, 99.5%, 130 nm) | 0303HW | 25g; |
| *Zinc Nanopowder (Zn, 99.9+%, 100 nm) | 0306JY | 25g; |
| *Zinc Nanopowder (Zn, 99.5%, 80 nm) | 0304HW | 25g; |
| *Aluminum Nitride Nanopowder (AlN, Amorphous, <0.5um, 99.9%) | 1004HW | 咨询 |
| Aluminum Nitride Nanopowder (AlN, 99.9 %, 0.5 um) | 1005HW | 咨询 |
| *Aluminum Nitride Nanopowder (AlN, 99.5 %, 70-80 nm) | 1002HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 500 μm) | 1175HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 50 μm) | 1177HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 40 μm) | 1179HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 20μm) | 1172HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 10μm) | 1169HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 5 μm) | 1165HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 2 um) | 1183HW | 1 kg; |
| Boron Carbide Powder (B4C, 99+%, 1-2 μm) | 1162HW | 咨询 |
| Boron Carbide Nanopowder (B4C, 99+%, 500 nm) | 1160HW | 500g; |
| Boron Carbide Nanopowder (B4C, 99%, 50nm) | 1161HY | 100g; |
| Boron Nitride Powder (BN, hexagonal, 99.8%, 0.6-1.2um) | 1182HW | 咨询 |
| Boron Nitride Nanopowder (BN, hexagonal, 99%, 137 nm) | 1180YL | 25g; |
| Boron Nitride Nanoplates (BN, 99.5+%, 100 nm) | 1183NJ | 100g; |
| Chromium Carbide Nanopowder (Cr3C2, 99.9%, <100 nm) | 0247HW | 500g; 1kg; |
| Hafnium Boride Nanopowder (HfB2, 99+%, 60 nm) | 1010JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 200 nm) | 1005JC | 500g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 60 nm) | 1006JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99%, 50nm) | 1022JC | kg; |
| Niobium Carbide Nanopowder (NbC, 99.9%, 500 nm) | 3860YM | 咨询 |
| Silicon Carbide Powder (SiC, 500 um, 99%, Hexagonal) | 4652HW | 1kg; ; |
| Silicon Carbide Powder (SiC, 50 um, 99%, Hexagonal) | 4654HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 40um, 99+%) | 4645HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 20um, 99+%) | 4643HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 10um, 99+%) | 4641HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 7um, 99+%) | 4639HW | 100g; 1kg; ; |
| Silicon Carbide Powder (SiC, beta, 99.8%, 5 μm) | 4637HW | 100g; ; |
| Silicon Carbide Powder (SiC, beta, 99+%, 2 μm) | 4635HW | 咨询 |
| Silicon Carbide Powder (SiC, alpha, 99.9%, 2um) | 4627HY | 1kg; |
| Silicon Carbide Powder (SiC, 500 nm, 99%, Cubic) | 4656HW | 1kg; ; |
| Silicon Carbide Nanopowder (SiC, beta, 99%, 80-100 nm) | Stock # 4629HW | 100g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 55 nm) | 4625HY | 100g; |
| Silicon Carbide Nanopowder (SiC, beta, 97.5%, 45-55 nm) | 4620KE | 200g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 30 nm) | 4626HY | 100 g; 150 g; |
| Silicon Carbide Nanowhisker (beta, SiC, 99+%) | 4622HW | 25g; |
| Silicon Nitride Nanopowder (Si3N4, amorphous, 98.5+%, 15-30 nm) | 4750KE | 100g; |
| Titanium Boride Powder (TiB2, 2-12 μm ) | 5180HW | 100g |
| *Titanium Carbide Powder (TiC, 1 micron, 99%) | 5218YL | 500g; |
| *Titanium Carbide Nanoparticles (TiC, 100-200nm, 99+%) | 5217HW | 1kg; |
| Titanium Carbide (TiC, 99+%, 100 nm) | 5217JC | 100g; |
| *Titanium Carbide (TiC, 98+%, 80 nm) | 5220HT | 25g; 100g; |
| *Titanium Carbide Nanopowder (TiC, 97+%, 50 nm) | 5216KE | 100g; |
| *Titanium Nitride Powder (TiN, 99%, 1-3um) | 5352JC | 500g; 1kg; |
| *Titanium Nitride Nanoparticles (TiN, 99%, 100-200 nm) | 5357HW | 500g; |
| *Titanium Nitride Nanopowder (TiN, 97+%, 20 nm) | 5350KE | 100g; |
| Tungsten Carbide/Cobalt Nanopowder (8wt%Co/WC, < 200 nm, 99.5%) | 5561HW | 100g |
| Zirconium Carbide Nanopowder (ZrC, 99%, 8 um) | 5905KE | 100g; 250g; 500g; |
| *Zirconium Carbide Nanopowder (ZrC, 97%, 60 nm) | 5901KE | 100g; |
| *Zirconium Nitride Nanopowder (ZrN, 99.5%, 1-3um) | 6101JC | 500g; kg; |
| Zirconium Boride Nanopowder (ZrB2, 99%, 60 nm) | 5950JC | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 500 nm) | 1037HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99+%, 500 nm) | 1038HT | 100g; |
| Aluminum Oxide Nanopowder (alpha, aluminate coated, 98+%, 500 nm) | 1039HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 200 nm) | Stock #:1040LQS | 100g |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 150 nm) | 1005MR | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 40-50 nm) | 1044HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha/theta, 99.99%, ~30nm ) | 1018WJ | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99+%, 500 nm) | 1045HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.97%, 20-30 nm) | 1020MR | 100g; 500g; 1kg; |
| Aluminum Oxide Nanopowder (gamma, 99.5%, 50 nm) | 1007XX | 咨询 |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.99%, 10 nm) | 1043HT | 100g; |
| Aluminum oxide nanopowder, (γ-phase) APS 20-30 nm, 99.95+% | 0125HW | 咨询 |
| Aluminum Oxide Nanopowder ( 99.99%, 30 nm ) for Lithium Batteries | 1016WJ | 咨询 |
| Aluminum Hydroxide Nanopowder (99.5 %, 50 nm) | 1040WJ | 咨询 |
| Boron Oxide Nanopowder (B2O3, 98%, 40-80 nm) | 1185DF | 咨询 |
| Boron Oxide Nanopowder (B2O3, 99%, 40-80 nm) | 1186DF | 1kg; |
| Bismuth Oxide Nanopowder (Bi2O3 , 99.9%, 100 nm) | 1171HT | kg; |
| Cerium Oxide, (CeO2, 99.99%, 200 nm) | 1445MG | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99%, 50-100 nm) | 1408HW | 100g; |
| Cerium Oxide (CeO2, 99.99%, 20-30 nm) | 1444ZQ | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99.9%, 15-30 nm) | 1406RE | 100g; |
| Cobalt(II,III) Oxide Nanopowder (Co3O4, 99%, 50-80 nm) | 1720HT | 咨询 |
| Chromium Oxide Powder (Cr2O3, 99.8%, 1 um) | 1920FY | 25g; 1kg; |
| Chromium Oxide Powder (Cr2O3, 99.9%, 100 nm) | 1925FY | 100g; 1kg; |
| Chromium Oxide Nanopowder (Cr2O3, 99+%, 60 nm) | 1910FY | 25g; |
| Copper(II) Oxide Nanopowder (CuO, 99+%, 30-50 nm) | 2110FY | 咨询 |
| Copper(I) Oxide Nanopowder (Cu2O, 99%, 30-50 nm) | 2113HW | 25g; 100g; 500g; 1kg; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 55 nm) | 2252YS | 25g; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 30-70 nm) | 2253ZQ | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 43 nm) | 2310ZQ | 65g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 41-53 nm) | 2350YS | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 20-30 nm) | 2330RE | 25g ; |
| Europium Oxide Nanopowder (Eu2O3, 99.995%, 58 nm) | 2410ZQ | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 45-58 nm) | 2450YS | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 30-50 nm) | 2411RE | 5g; |
| Iron(III) Oxide Nanopowder (Fe2O3, gamma, 99.98%, 50 nm) | 2527YM | 1kg |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30-50 nm) | 2520ZH | 25g; 100g; |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30 nm) | 2525WJ | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 100-200 nm) | 2653HW | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 97%, 50-100 nm) | 2650TS | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, SSA: 9-14 m2/g, 50-100 nm) | 2655HW | 100g; 500g; 1kg; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 30 nm) | 2651WJ | 100g; |
| Iron Oxide Nanopowder (Fe3O4, PVP coated, 99+%, 20-30 nm) | 2657HW | 100g; 1kg; |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9+%, 20-80 nm) | 2680ZQ | 咨询 |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9%, 15-30 nm) | 2681RE | 咨询 |
| Hafnium Oxide Powder (HfO2, 99.99%, 48um) | 1045HW | 咨询 |
| Hafnium Oxide Powder (HfO2, 99%, 45um) | 1042HW | 咨询 |
| Indium Oxide Nanopowder (In2O3, 99.99%, 100-200 nm) | 2711TN | 咨询 |
| Indium Hydroxide Nanopowder (In(OH)3, 99.99%, 20-70 nm) | 2810TN | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99%, 50 nm) | 2922RE | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99.99%, 15-30 nm) | 2920RE | 咨询 |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40-60 nm) | 3305HT | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 1kg; |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40 nm) | 3304HT | 咨询 |
| Magnesium Hydroxide Nanopowder (Mg(OH)2, 98+%, 100 nm) | 3321HT | 咨询 |
| Molybdenum(VI) Oxide Nanopowder (MoO3 , 99.5%, 100 nm) | 3851XW | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9+%, 83 nm) | 3910ZQ | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 49-64 nm) | 3950YS | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 15-30 nm) | 3911RE | 25g; |
| Nickel Oxide Nanopowder (Ni2O3, 99.9%, 20-30 nm) | 4216HW | 100g; |
| Praseodymium Oxide Nanopowder (Pr6O11, 99.9%, 15-30 nm) | 4451RE | 25g; |
| Antimony Oxide Nanoparticles (Sb2O3, 99.99%, 20-30nm) | 6850HW | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.99%, 1-3.5 μm) | 4856WG | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.998%, 1-3.5um) | 4855WG | 咨询 |
| Silicon Oxide Nanopowder (SiO2 , 99+%, 20 nm) | 4830HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4831HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4832HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4833HT | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 42-55 nm) | 4950YS | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 15-30 nm) | 4951RE | 咨询 |
| Titanium Oxide Nanopowder (TiO2, amorphous/anatase, 99+%, 5 nm) | 5416HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99%, 10-30 nm) | 5420HT | 咨询 |
| Titanium Oxide Nanopowder(TiO2, anatase, 99%,15 nm) | 5430MR | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99+%, 10 nm) | 5417HT | 咨询 |
| Titanium Oxide Nanopowder (tungsten oxide doped, TiO2/WO3, anatase, 10 nm) | 5418HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 5 nm) | 5421ZH | 咨询 |
| Titanium Oxide Nanotubes (TiO2, anatase, 99%, 10-15 nm) | 5432HW | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase/rutile, 99+%, 20 nm) | 5419HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 30 nm) | 5426HT | 咨询 |
| Titanium oxide (silica, alumina & stearic acid coated, anatase/rutile, 30 nm) | 5427HT | 咨询 |
| Titanium Oxide Nanopowder (silica, alumina & silicone oil coated, anatase/rutile, 30 nm) | 5428HT | 咨询 |
| Titanium oxide, silica coated (anatase/rutile, 20 nm) | 5422HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 20 nm) | 5423HT | 咨询 |
| Titanium oxide, silica & stearic acid coated (anatase/rutile, 20 nm) | 5424HT | 咨询 |
| Titanium oxide, silica & silicone oil coated (anatase/rutile, 20 nm) | 5425HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 500 nm) | 5429HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 150 nm) | 5430HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 100 nm) | 5431HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 60 nm) | 5486WJ | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 20-50 nm) | 5484WJ | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0302HT | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0301HT | 咨询 |
| Vanadium Oxide Nanopowder (VO2, 99.9+%, 100 - 200 nm) | 5495HW | 咨询 |
| 1.5% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5499HW | 咨询 |
| 1% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5498HW | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.5%, 60-120 nm) | 5508YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.9+%, 40-50 nm) | 5506BD | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm) | 5505YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm, PVP-coated) | 5506YL | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 50-70 nm) | 5610ZQ | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.99%, 20-40 nm) | 5611RE | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.9%, 32-36 nm) | 5650YS | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 20-40 nm) | 5611ZQ | 咨询 |
| Ytterbium Oxide Nanopowder (Yb2O3, 10-80 nm, 99.9%) | 5671RE | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99+%, 800 nm) | 5816HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 30 nm) | 5811HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, hydrophilic & lipophilic) | 5812HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, silicone oil coated) | 5814HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, stearic acid coated) | 5815HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 20 nm) | 5810HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99+%, 50 nm) | 5936HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99.5+%, 20 nm) | 5931HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/3 mol% Y2O3, 99.5+%, 15-50 nm) | 5932HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/5 mol% Y2O3, 99.5+%, 15-50 nm) | 5934HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/8 mol% Y2O3, 99.5+%, 15-50 nm) | 5933HT | 咨询 |
| Zirconia Nanopowder, Calcia Doped (ZrO2/8 mol%CaO, 99.9%, 20-30 nm) | 5934ZS | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 400 nm) | 1146DY | 100g; |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 300 nm) | 1144DY | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.5%, 100-200 nm) | 1148DY | 咨询 |
| Cobalt Iron Oxides Nanopowder (CoFe2O4, 98%, 35-55 nm) | 1510FY | 25g ; 100g; |
| Cobalt-Zinc Iron Oxide Nanopowder (Co0.5Zn0.5Fe2O4, 99.5%, 30-50 nm) | 1515FY | 25g ; 100g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 90wt%:10wt%, 99.99%, 20-70 nm) | 2730TN | 5g; 25g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 95 wt%:5 wt%, 99.99%, 30-50 nm) | 2731BY | 5g; 25g; |
| Nickel-Zinc Iron Oxide Nanopowder (Ni0.5Zn0.5Fe2O4, 98.5%, 10-30 nm) | 4115FY | 100g; 500g; |
| *Ni80Fe17Mo3 permalloy nanopowder (99+%, 70 nm) | 9288HW | 100g; |
| Yttrium Aluminate w/Nd doped (Y2.98Nd0.02Al5O12, Nd-YAG, 99.5%, 40 nm) | 5571FY | 25g; 100g; |
| Zinc Iron Oxide Nanopowder (ZnFe2O4, 98.5%, 40 nm) | 5710FY | 100g; |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

Columbia Biosciences 公司成立于2007年,主要生产天然荧光蛋白、抗体交联物及检测试剂盒。Columbia Biosciences具有成熟的,对微藻生物的培养、分离、纯化、及藻类荧光蛋白基团接合技术,并将其应用于生命科学产品、诊断工具中,并推广到全世界。
Columbia Biosciences, founded in 2007, manufactures natural fluorescent proteins, antibody conjugates and assay kits. Columbia's expertise lies in the ability to integrate microalgae cultivation with the isolation, purification and conjugation of algal protein fluorophores. The company's fluorophores are integrated into a large number of life science products and diagnostic tools and, are distributed globally.
Columbia Biosciences的主要产品包括:
Cyclic AMP Kit
PHYCOBILIPROTEINS AND PERCP
TR-FRET REAGENTS
ANTIBODY CONJUGATES
Conjugation Kits
Europium Conjugates
Isotype Controls
POC Reagents
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Columbia Biosciences"> Columbia Biosciences
艾美捷科技代理Scripps Laboratories 品牌。
Scripps Laboratories 是一家专注于生物化学试剂和免疫分析产品的公司,提供高质量的抗体、酶、蛋白质和免疫分析试剂盒,支持生命科学研究和临床诊断。Scripps Laboratories公司采用先进的生产和质控技术,确保产品的高质量和一致性;用于免疫学、细胞生物学和分子生物学研究;疾病诊断、生物标志物检测和健康监测;药物筛选、药效评估和毒性测试;生物制药、疫苗开发和生物材料研究。
Scripps Laboratories主要产品与服务包括:
(1)抗体:提供多种高特异性和高灵敏度的抗体,用于免疫学研究和诊断。
(2)酶和蛋白质:提供多种高纯度的酶和蛋白质,用于生物化学和分子生物学研究。
(3)免疫分析试剂盒:提供多种免疫分析试剂盒,包括 ELISA 试剂盒、蛋白质印迹试剂和细胞分析试剂。
(4)定制服务:根据客户需求,提供定制化的抗体和免疫分析试剂开发服务。

Immunostar公司主要制造和销售各种免疫多克隆和单克隆神经学的一抗。
ImmunoStar is the original manufacturer of primary polyclonal and monoclonal antibodies. We take pride in selling to neuroscience researchers at a high-titer and fair price. Since 1975, we have earned a reputation for trusted antibodies that work every time.
Our quality reputation has been validated in over seven thousand citations in biomedical literature of ImmunoStar antibodies. You can find and search them all on our Publications page. This user-friendly database can be searched by antibody, research area, species reactivity, or keyword. ImmunoStar’s core antibodies were previously sold and cited under the names Diasorin, Incstar, and ImmunoNuclear.
Immunostar的主要产品包括:
(1)Antibodies
5-HIAA (5-Hydroxyindoleacetic Acid) Antibody
5-HT (Serotonin) 1A Receptor Antibody
5-HT (Serotonin) 2A Receptor Antibody等
(2)Peptide Controls
5-HT (Serotonin) / BSA Conjugate Control
nNOS:C-Terminal Peptide Control
Opioid Receptor-Mu Peptide Control等
(3)Testimonials
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ImmunoStar"> ImmunoStar
ChromaDex公司成立于1999年,主要产品天然提取物标准物质,同时还提供天然提取物检测、评价、开发服务。ChromaDex始终紧跟政府、市场及客户要求,持续推出新产品,以满足不断发展的检测方法。
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. Our flagship ingredient, NIAGEN®, is sold directly to consumers as TRU NIAGEN® and is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®.
ChromaDex的主要产品包括:
Phytochemical Reference Standards
Botanical Reference Materials
Natural Product Libraries
NIAGEN
pTeroPure
PURENERGY
IMMULINA
AnthOrigin
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ChromaDex"> ChromaDex
艾美捷科技有限公司代理Complement Technology全系列产品。
Complement Technology公司致力于为生物医学研究提供最高质量的补体试剂。Complement Tech的研发人员在补体相关试剂领域拥有80多年的丰富经验,是补体试剂的原始制造商。
Complement Technology公司的主要产品包括:
| Purified Proteins | |||
| 产品名称 | 货号 | mg/ml | µg/vial |
| C1 (Pure) | A098 | 0.2 | 200 |
| C1q | A099 | 1 | 1000 |
| C1q (40% Glycerol) | A100 | 1 | 1000 |
| C1r Proenzyme | A101 | 0.5 | 100 |
| C1r Enzyme | A102 | 1 | 250 |
| C1s Proenzyme | A103 | 1 | 250 |
| C1s Enzyme | A104 | 1 | 250 |
| C1 Esterase Inhibitor | A140 | 1 | 1000 |
| C1s-C1INH Complex *(NEW)* | C1040 | 0.5 | 50 |
| C2 | A112 | 0.5 | 50 |
| C3 | A113 | 1 | 250 |
| C3 (concentrated) | A113c | 5 | 1000 |
| C3a | A118 | 0.5 | 50 |
| C3a desArg | A119 | 0.5 | 50 |
| C3b | A114 | 1 | 250 |
| iC3b | A115 | 1 | 250 |
| C3c | A116 | 1 | 250 |
| C3d | A117 | 1 | 100 |
| C4 | A105 | 1 | 250 |
| C4 (concentrated) | A105c | 4 | 1000 |
| C4a | A106 | 0.5 | 50 |
| C4a desArg | A107 | 0.5 | 50 |
| C4b | A108 | 1 | 250 |
| C4b Binding Protein | A109 | 1 | 250 |
| C5 | A120 | 1 | 250 |
| C5a | A144 | 0.5 | 30 |
| C5a (300) | A144(300) | 0.5 | 300 |
| C5a desArg | A145 | 0.5 | 50 |
| C5b,6 | A122 | 0.2 | 50 |
| C6 | A123 | 1 | 250 |
| C7 | A124 | 1 | 250 |
| C8 | A125 | 1 | 250 |
| C9 | A126 | 1 | 250 |
| SC5b-9 Complex | A127 | 1 | 100 |
| Factor B | A135 | 1 | 250 |
| Factor D | A136 | 0.1 | 25 |
| Factor H | A137 | 1 | 250 |
| Factor H (conc.) | A137c | 10 | 10000 |
| Factor I | A138 | 1 | 100 |
| Factor P (Properdin) | A139 | 1 | 100 |
| Cobra Venom Factor (USA Only) | A150 | 1 | 1000 |
| Factor Ba | A154 | 1 | 100 |
| Factor Bb | A155 | 1 | 250 |
| Animal Proteins | |||
| 产品名称 | 货号 | mg/ml | µg/vial |
| Cyno C3 (USA Only) | CY113 | 1 | 100 |
| Cyno C3b (USA Only) | CY114 | 1 | 100 |
| Mouse C1q | M099 | 1 | 100 |
| Mouse C3 | M113 | 1 | 100 |
| Mouse C3b | M114 | 1 | 100 |
| Rat C1q | R099 | 1 | 100 |
| See Polyclonal Antisera page for Anti-Mouse C3 | M213 | - | - |
| Anaphylatoxin | |||
| 产品名称 | 货号 | mg/ml | µg/vial |
| C3a | A118 | 0.5 | 50 |
| C3a desArg | A119 | 0.5 | 50 |
| C4a | A106 | 0.5 | 50 |
| C4a desArg | A107 | 0.5 | 50 |
| C5a | A144 | 0.5 | 30 |
| C5a desArg | A145 | 0.5 | 50 |
| C5a (300) | A144(300) | 0.5 | 300 |
| Complement Assay Reagents | |||
| 产品名称 | 货号 | 体积 | |
| GVBo (without Ca and Mg) - 250ml | B103 | 250ml | |
| GVBo (without Ca and Mg) - 1L | B101 | 1 Liter | |
| GVB++ (with Ca and Mg) - 250ml | B102 | 250ml | |
| GVB++ (with Ca and Mg) - 1L | B100 | 1 Liter | |
| GVBE (with EDTA) - 250ml | B104 | 250ml | |
| GVBE (with EDTA) - 1L | B105 | 1 Liter | |
| SGVB++ (low ionic strength w/Sucrose, Ca and Mg) - 250ml | B110 | 250ml | |
| SGVB++(low ionic strength w/Sucrose, Ca and Mg) - 1L | B111 | 1 Liter | |
| VBS++ (with Ca and Mg) - 250ml | B112 | 250ml | |
| VBS++ (with Ca and Mg) - 1L | B113 | 1 Liter | |
| EA (Ab-sensitized sheep E) - 5ml | B200 | 5ml @ 5x10⁸/ml | |
| EA (Ab-sensitized sheep E) - 10ml | B201 | 10ml @ 5x10⁸/ml | |
| EA (Ab-sensitized sheep E) - 20ml | B202 | 20ml @ 5x10⁸/ml | |
| Es (sheep E) | B210 | 20ml @ 5x10⁸/ml | |
| Er (rabbit E) - 5ml | B300 | 5ml @ 5x10⁸ml | |
| Er (rabbit E) - 10ml | B301 | 5ml @ 5x10⁸/ml | |
| Er (rabbit E) - 20ml | B302 | 20ml @ 5x10⁸/ml | |
| Zymosan (preactivated) | B400 | 10ml @ 1x10⁹/ml | |
| MgEGTA | B106 | 10ml @ 0.1M | |
| MCAR | B250 | 1.0 ml | |
| Hemolysin | Hemolysin | 2.0 ml | |
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Complement Technology"> Complement Technology

艾美捷科技代理InSCREENeX品牌全系列产品
InSCREENeX GmbH成立于2009年,位于德国布伦瑞克亥姆霍兹感染研究中心内,是一家专注于开发细胞筛选技术的德国生物技术公司,InSCREENeX生产用于药物开发的细胞系统。InSCREENeX在该领域拥有超过15年的哺乳动物细胞基因修饰专业知识,在此期间成功开发了SCREENflex和CI-SCREEN这两项高度创新的技术。
利用SCREENflex技术,可以根据客户需求创建稳定的重组哺乳动物细胞。这种方法具有以下优势:快速建立所需的测试系统、目标基因的稳定表达,以及能够以不同水平调控该基因的表达。SCREENflex 技术具有普适性,已成功应用于建立多种蛋白质类别,例如 GPCRs(G蛋白偶联受体)、离子通道、抗体和细胞因子。InSCREENeX公司的产品包括稳定表达细胞系、永生化细胞系以及细胞培养试剂。

▍InSCREENeX产品线
● 稳定表达细胞系:包括离子通道、GPCRs、整合素及其他受体的稳定过表达细胞系
| 品名 | 货号 | Target | Cell background |
| CHO-Nav1.8 | INS-SF-1003 | human Nav1.8 plus beta subunit 1 | CHO |
| CHO-Nav1.7 | INS-SF-1037 | human Nav1.7 | CHO |
| CHO-PD-L1 | INS-SF-1028 | human PD-L1 | CHO |
| CHO-EpCAM | INS-SF-1027 | human EpCAM | CHO |
| CHO-PDCD1 | INS-SF-1026 | human PDCD1 | CHO |
| CHO-BCMA | INS-SF-1025 | human BCMA | CHO |
| CHO-B7H3 | INS-SF-1019 | B7H3 | CHO |
| HEK293-CTLA4 | INS-SF-1014 | CTLA4 | HEK293 |
| CHO-CTLA4 | INS-SF-1013 | CTLA4 | CHO |
| HEK293-CXCR4 | INS-SF-1006 | CXCR4 | HEK293 |
| CHO-CXCR4 | INS-SF-1004-L | CXCR4 | CHO |
| CHO-CXCR4 | INS-SF-1004-MH | CXCR4 | CHO |
| HEK293-CXCR7 | INS-SF-1009 | CXCR7 | HEK293 |
| CHO-CXCR7 | INS-SF-1007-L | CXCR7 | CHO |
| CHO-CXCR7 | INS-SF-1007-MH | CXCR7 | CHO |
| HEK293-FOLR1 | INS-SF-1018 | FOLR1 | HEK293 |
| CHO-FOLR1 | INS-SF-1017 | FOLR1 | CHO |
| HEK293-HER2 | INS-SF-1012 | HER2 | HEK293 |
| CHO-HER2 | INS-SF-1010-MH | HER2 | CHO |
| CHO-HER2 | INS-SF-1010-H | HER2 | CHO |
| HEK293-TACD2 | INS-SF-1016 | TACD2 | HEK293 |
| CHO-TACD2 | INS-SF-1015 | TACD2 | CHO |
| HEK293-FAP | INS-SF-1001 | FAP | HEK293 |
| HEK293-CCR8 | INS-SF-1024 | CCR8 | HEK293 |
| CHO-CCR8 | INS-SF-1023 | CCR8 | CHO |
● 永生化细胞系:来自不同物种的功能性永生化细胞系。
| 品名 | 货号 | Species | Organ/Tissue |
| CI-pNaEC | INS-CI-1029 | porcine | Nasal epithel |
| CI-muMEC | INS-CI-1004 | murine | Vascular endothel |
| CI-muHepa | INS-CI-1012 | murine | Liver, hepatocytes |
| CI-muINTEPI | INS-CI-1007 | murine | Intestinal epithel (fetal) |
| CI-muADINTESTI | INS-CI-1018 | murine | Intestinal epithel (adult) |
| CI-huThyrEC | INS-CI-1017 | human | Thyroid epithel |
| CI-huVEC | INS-CI-1002 | human | Endothel, Umbilical vein |
| CI-huOB | INS-CI-1005 | human | Osteoblasts |
| CI-huMEC | INS-CI-1008 | human | Microvascular endothel |
| CI-huFIB | INS-CI-1010 | human | Fibroblasts |
| CI-huEGC | INS-CI-1030 | human | Enteric glial cells (intestine) |
| CI-huBroBEC | INS-CI-1025 | human | Lung, bronchial epithel |
| CI-hAELVi | INS-CI-1015 | human | Lung, Alveoli |
| CI-huArlo | INS-CI-1031 | human | Lung, Alveoli |
● Reagents and Consumables产品
| 分类 | 品名 | 货号 | 规格 |
| Culture Media | CHO Growth Medium A | INS-ME-1039 | 500 ml |
| Culture Media | CHO Growth Medium B | INS-ME-1040 | 500 ml |
| Culture Media | FasTEER Medium | INS-ME-1032-100 | 100 ml |
| Culture Media | HEK293 Growth Medium A | INS-ME-1041 | 500 ml |
| Culture Media | huAEC Medium | INS-ME-1013-100 | 100 ml |
| Culture Media | huAEC Medium | INS-ME-1013-500 | 500 ml |
| Culture Media | huBroBEC Medium | INS-ME-1033 | 500 ml |
| Culture Media | huEGC Medium | INS-ME-1027 | 500 ml |
| Culture Media | huFIB Medium | INS-ME-1001 | 500 ml |
| Culture Media | huMEC Medium | INS-ME-1012 | 500 ml |
| Culture Media | huOB Differentiation Medium | INS-ME-1007 | 100 ml |
| Culture Media | huOB Maintenance Medium | INS-ME-1006 | 500 ml |
| Culture Media | huThyrEC Medium | INS-ME-1017 | 500 ml |
| Culture Media | huVEC Medium | INS-ME-1011 | 500 ml |
| Culture Media | muADINTESTI Medium | INS-ME-1023 | 500 ml |
| Culture Media | muINTEPI Medium | INS-ME-1005 | 500 ml |
| Culture Media | muMEC Medium | INS-ME-1004 | 500 ml |
| Culture Media | pNaEC Medium | INS-ME-1038 | 500 ml |
| Coating Solutions | Coating Solution | INS-SU-1026 | 50ml;100ml;300ml |
| Freezing Media | Cell Freezing Medium | INS-SU-1027 | 30 ml |
▍InSCREENeX提供的服务
● Landing Pad Cells:将目标单拷贝整合到CHO、HEK293 和 Llama主细胞系中,快速生成细胞系并进行变体库整合。
● Random Integration:通过病毒或非病毒方法将目标基因随机整合到任何细胞系中。
● Cell culture services:高度定制化的细胞系服务,包括细胞库构建、细胞存储、制备:细胞沉淀(Pellets)、细胞裂解液(Lysates)、DNA、RNA、培养基优化,原代细胞分离与分选等。
● Assay services:建立并运行检测方法,包含检测方法建立与优化,代运行检测服务等。
● Molecular biology services:包含克隆构建,质粒制备,DNA/RNA分离提取与制备,慢病毒生产等服务。
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理InSCREENeX品牌全系列产品"> 艾美捷科技代理InSCREENeX品牌全系列产品
BroadPharm位于美国加州圣迭戈市,致力于为世界范围内的客户提供高纯度的PEG Linkers,Click Chemistry Tools及生物标记试剂,如染料标记、生物素标记等。
BroadPharm is a leading customer-focused biotech company in San Diego, California. We are dedicated to manufacturing and supplying high purity PEG Linkers, Click Chemistry Tools and advanced Bio-labeling reagents such as Dye Labeling and Biotin Labeling compounds to our clients worldwide.
主要产品包括:
(1)PEG Linkers (in stock)
Alkyne PEG、Cleavable PEG、PEG Acid、PEG Tosylate、PEG-X-PEG、Amino PEG、DBCO PEG、PEG Aldehyde、Poly PEG、Aminooxy PEG、DNP-PEG、PEG Azide、Propargyl PEG、BCN-PEG、DOTA PEG、PEG Maleimide、Sugar PEG、Benzyl-PEG、DSPE PEG、PEG NHS ester、TCO-PEG、Biotin PEG、Fluorescent PEG、PEG Peptide、Tetrazine-PEG、Bis-PEG-acid、Fmoc PEG、PEG PFP ester、Thiol PEG、Bis-PEG-NHS、Hydroxy PEG、PEG Phosphonate、Boc-PEG、m-PEG、PEG Silane、Branched PEG、MeNH-PEG、PEG Sulfonic acid、Bromo PEG、Non-PEG linker
(2)Click Chemistry Tools
Azide, Alkyne, DBCO, TCO, Tetrazine, BCN
(3)Dye Labeling
Cyanine, Fluorescein, Rhodamine, BDP and Pyrene dyes
(4)Biotin Labeling
Amine reactive, carboxyl reactive, carbonyl reactive, water-soluble, cleavable
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BroadPharm"> BroadPharm地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:18327026838
邮箱:sales@amyjet.com
0.3407